Effect of Adalimumab on Work Productivity and Indirect Costs in Moderate to Severe Crohn’s Disease: A Meta-Analysis

David G Binion; Edouard Louis; Bas Oldenburg; Parvez Mulani; Arielle G Bensimon; Mei Yang; Jingdong Chao

doi:10.1155/2011/938194

Canadian Journal of Gastroenterology (Jan 2011)

Effect of Adalimumab on Work Productivity and Indirect Costs in Moderate to Severe Crohn’s Disease: A Meta-Analysis

David G Binion,
Edouard Louis,
Bas Oldenburg,
Parvez Mulani,
Arielle G Bensimon,
Mei Yang,
Jingdong Chao

Affiliations

David G Binion: Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Edouard Louis: University of Liège and CHU Liège, Liège, Belgium
Bas Oldenburg: University Medical Centre, Utrecht, The Netherlands
Parvez Mulani: Abbott Laboratories, Abbott Park, Illinois, USA
Arielle G Bensimon: Analysis Group Inc, Boston, Massachusetts, USA
Mei Yang: Abbott Laboratories, Abbott Park, Illinois, USA
Jingdong Chao: Abbott Laboratories, Abbott Park, Illinois, USA

DOI: https://doi.org/10.1155/2011/938194
Journal volume & issue: Vol. 25, no. 9
pp. 492 – 496

Abstract

Read online

OBJECTIVE: To assess the effect of adalimumab on work productivity and indirect costs in patients with Crohn’s disease (CD) using a meta-analysis of clinical trials.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal